vTv Therapeutics Inc.

19.66
1.26 (6.85%)
At close: Feb 28, 2025, 3:53 PM
19.66
0.00%
After-hours: Feb 28, 2025, 03:53 PM EST

vTv Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
Net Income -20.25M -25.07M -17.73M -12.8M -21.94M -23.84M -54.65M -55.35M -41.11M -36.1M -48.2M
Depreciation & Amortization 90K 92K 89K 94K 39K 218K 197K 265K 501K 864K 1.09M
Stock-Based Compensation 1.58M 1.27M 2.36M 1.01M 1.52M 2.68M 3.65M 2.64M 859K n/a 2.92M
Other Working Capital 1.39M 6.36M -1M 420K -2.05M -15.54M 10.39M -410K -1.37M -951K -8.82M
Other Non-Cash Items -4.89M 2.3M -4.06M 380K 532K 1.01M 1.03M 154K 722K 6.14M 10.47M
Deferred Income Tax n/a n/a n/a -3.98M -1.11M 626K 179K -2K 38K n/a 862K
Change in Working Capital 4.39M 5.38M 35K -2.71M -2.05M -7.54M 5.04M 4.09M 2.04M -1.68M -8.82M
Operating Cash Flow -19.08M -16.02M -19.31M -18M -23.02M -26.86M -44.56M -48.21M -36.95M -30.78M -41.68M
Capital Expenditures n/a -21K n/a n/a -70K -5K -57K -87K -104K -33K -181K
Acquisitions 4.4M n/a n/a n/a 312K 12K 32K 4K 25K -140K n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments 4.4M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies -4.4M n/a n/a n/a 312K 12K 32K 4K 25K 334K 25K
Investing Cash Flow 4.4M -21K n/a n/a 242K 7K -25K -83K -79K 161K -156K
Debt Repayment -33K -32K 172K -4.96M -10.07M -4.89M 7.5M 12.47M 19.29M 33.41M 39.03M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a 302K 923K n/a -2.5M n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a 14.79M 26.8M n/a n/a n/a n/a -673K -1.42M -2.5M 1.76M
Financial Cash Flow 12M 14.75M 26.98M 19.47M 22.87M 16.61M 7.5M 11.79M 123.64M 30.91M 40.8M
Net Cash Flow -2.68M -1.29M 7.67M 1.47M 94K -10.24M -37.09M -36.5M 86.62M 295K -1.03M
Free Cash Flow -19.08M -16.04M -19.31M -18M -23.09M -26.86M -44.62M -48.3M -37.05M -30.81M -41.87M